Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$1.61M Sell
11,657
-209
-2% -$32.9K 0.1% 187
2015
Q2
$1.82M Buy
11,866
+1,281
+12% +$205K 0.11% 187
2015
Q1
$1.69M Buy
10,585
+696
+7% +$110K 0.1% 208
2014
Q4
$1.57M Sell
9,889
-910
-8% -$142K 0.1% 198
2014
Q3
$1.52M Sell
10,799
-1,303
-11% -$170K 0.11% 182
2014
Q2
$1.43M Buy
12,102
+1,599
+15% +$185K 0.1% 195
2014
Q1
$1.29M Sell
10,503
-384
-4% -$46.6K 0.1% 199
2013
Q4
$1.24M Buy
10,887
+1,467
+16% +$167K 0.1% 193
2013
Q3
$1.05M Sell
9,420
-3,442
-27% -$373K 0.1% 189
2013
Q2
$1.27M Buy
+12,862
New +$1.33M 0.13% 149

Other funds holding AMGN

OFI Advisors's AMGN Position: Q3 2015 in Review

OFI Advisors reduced its Amgen (AMGN) stake by 1.8% in Q3 2015, selling an estimated $32.9K and leaving 11,657 shares worth $1.61M. The position accounts for 0.1% of the portfolio, ranked #187.

OFI Advisors first reported a position in AMGN in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.82M in Q2 2015. 1,380 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

  • OFI Advisors held 11,657 shares of Amgen worth $1.61M as of Q3 2015.
  • OFI Advisors sold 209 Amgen shares in Q3 2015, an estimated $32.9K.
  • Amgen made up 0.1% of OFI Advisors's portfolio in Q3 2015, its #187 holding.
  • OFI Advisors first reported a position in Amgen in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Amgen position peaked at $1.82M in Q2 2015.
  • 1,380 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.